31Jul
Department of Justice fines pharmaceutical company
Compliance Today (August 2020) - On May 7, the Department of Justice’s Antitrust Division announced a deferred prosecution agreement, in which Apotex Corp. agreed to pay a $24.1 million criminal penalty for price-fixing. The Florida-based company conspired with competitors to increase and maintain the price of pravastatin, a commonly prescribed cholesterol medication that lowers the risk of heart disease and stroke....
By:
Health Care Compliance Association (HCCA)
Related
This brief guide provides updates on the impact of COVID-19 on merger control reviews around the wor...
Read More >
Effective January 1, 2020, employers may put aside pre-tax funds into a health reimbursement arrange...
Read More >
A challenge to the interpretation of a project condition of approval may be filed more than 90 days ...
Read More >
As “whistleblower” issues pervade national headlines, lawmakers in some jurisdictions, including N...
Read More >
Many commentators predicted a boom in M&A and initial public offerings (IPOs) in the U.K. in 2020, a...
Read More >
Plumbing Company Subjected Latino Employees to Hostile and Segregated Working Environment as Well as...
Read More >